| 1 | 4030988 | [Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies]. | J Chromatogr | 1985 Jun 14 |
1 |
| 2 | 6424592 | Effect of sultopride on prolactin secretion in rats. | Arch Int Pharmacodyn Ther | 1984 Feb |
8 |
| 3 | 7337503 | Development of radioimmunoassay for sultopride and sulpiride. | Arch Int Pharmacodyn Ther | 1981 Dec |
1 |
| 4 | 7802104 | Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. | Am J Psychiatry | 1995 Jan |
1 |
| 5 | 7894879 | Treatment of negative symptoms in schizophrenia with amisulpride. | Br J Psychiatry | 1995 Jan |
1 |
| 6 | 8935811 | In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia. | Psychopharmacology (Berl) | 1996 Mar |
1 |
| 7 | 8996184 | Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. | J Pharmacol Exp Ther | 1997 Jan |
2 |
| 8 | 8996185 | Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. | J Pharmacol Exp Ther | 1997 Jan |
1 |
| 9 | 9165379 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. | J Affect Disord | 1997 Apr |
1 |
| 10 | 9218164 | Clinical update on amisulpride in deficit schizophrenia. | Int Clin Psychopharmacol | 1997 May |
1 |
| 11 | 9545996 | Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. | Am J Psychiatry | 1998 Apr |
1 |
| 12 | 9892856 | Amisulpride versus amineptine and placebo for the treatment of dysthymia. | Neuropsychobiology | 1999 |
1 |
| 13 | 9894580 | Neuroendocrine response to antipsychotics: effects of drug type and gender. | Biol Psychiatry | 1999 Jan 1 |
2 |
| 14 | 10200742 | Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group. | Am J Psychiatry | 1999 Apr |
1 |
| 15 | 10594669 | Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat. | Eur J Neurosci | 1999 Dec |
1 |
| 16 | 11270918 | In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia. | J Clin Psychopharmacol | 2001 Apr |
1 |
| 17 | 11873706 | Atypical antipsychotics: mechanism of action. | Can J Psychiatry | 2002 Feb |
1 |
| 18 | 12144950 | Effect of the amisulpride isomers on rat prolactinemia. | Eur J Pharmacol | 2002 Jul 19 |
1 |
| 19 | 12165366 | SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. | Psychiatry Res | 2002 Aug 20 |
1 |
| 20 | 12207145 | Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels. | Neuropsychobiology | 2002 |
5 |
| 21 | 12232542 | [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. | Encephale | 2002 Jul-Aug |
3 |
| 22 | 12693427 | Amisulpride: is there a treatment for negative symptoms in schizophrenia patients? | Schizophr Bull | 2002 |
1 |
| 23 | 13130349 | [Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine] | Psychiatr Prax | 2003 May |
3 |
| 24 | 14509051 | [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. | Psychiatr Prax | 2003 May |
1 |
| 25 | 14575800 | The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms. | Eur J Pharmacol | 2003 Oct 8 |
1 |
| 26 | 14997280 | Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients. | Psychopharmacology (Berl) | 2004 Sep |
3 |
| 27 | 15225684 | A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder. | Pharmacol Res | 2004 Sep |
1 |
| 28 | 15665803 | Hyperprolactinemia after low dose of amisulpride. | Neuro Endocrinol Lett | 2004 Dec |
1 |
| 29 | 16252067 | Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). | J Neural Transm (Vienna) | 2006 Jul |
6 |
| 30 | 16288681 | The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride. | Int J Neuropsychopharmacol | 2006 Oct |
1 |
| 31 | 16874502 | [Differences between men and women in side effects of second-generation antipsychotics]. | Nervenarzt | 2007 Jan |
1 |
| 32 | 16938372 | Amisulpride-induced hyperprolactinemia is reversible following discontinuation. | Prog Neuropsychopharmacol Biol Psychiatry | 2007 Jan 30 |
4 |
| 33 | 17050656 | Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study. | J Psychopharmacol | 2007 Jun |
1 |
| 34 | 17285098 | Atypical antipsychotics and pituitary neoplasms in the WHO database. | Psychopharmacol Bull | 2007 |
1 |
| 35 | 17356308 | Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study. | Neuropsychobiology | 2006 |
3 |
| 36 | 17675915 | [Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics]. | Encephale | 2007 Mar-Apr |
1 |
| 37 | 18063941 | Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients. | Neuro Endocrinol Lett | 2007 Dec |
1 |
| 38 | 18203048 | Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. | Pharmacopsychiatry | 2008 Jan |
1 |
| 39 | 18477617 | Prolactin and dopamine: what is the connection? A review article. | J Psychopharmacol | 2008 Mar |
1 |
| 40 | 18710798 | Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. | Schizophr Res | 2008 Oct |
1 |
| 41 | 18777019 | Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum. | Psychopharmacology (Berl) | 2008 Dec |
1 |
| 42 | 18848860 | Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. | Prog Neuropsychopharmacol Biol Psychiatry | 2008 Dec 12 |
2 |
| 43 | 19910716 | Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics. | J Clin Psychopharmacol | 2009 Dec |
1 |
| 44 | 20218789 | Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. | World J Biol Psychiatry | 2010 Mar |
1 |
| 45 | 21289169 | Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices. | J Neurosci | 2011 Feb 2 |
1 |
| 46 | 21385106 | Risk of osteoporosis and fracture incidence in patients on antipsychotic medication. | Expert Opin Drug Saf | 2011 Jul |
1 |
| 47 | 21663752 | Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells. | Neuropharmacology | 2011 Sep |
14 |
| 48 | 21670104 | Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. | Mol Pharmacol | 2011 Sep |
2 |
| 49 | 22250612 | Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients. | Psychiatry Clin Neurosci | 2012 Feb |
4 |
| 50 | 22309430 | Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report. | J Med Case Rep | 2012 Feb 6 |
1 |